Radiofrequency thermal ablation of renal tumors.
Radiol Med
; 119(7): 499-511, 2014 Jul.
Article
em En
| MEDLINE
| ID: mdl-25024061
ABSTRACT
Percutaneous radiofrequency ablation (PRFA) of renal malignancies is currently a therapeutic option for patients who are not able to undergo surgery. Some authors consider PRFA as the therapeutic standard in the treatment of renal neoplasms in non-operable patients due to comorbid conditions and in patients with mild-moderate renal failure, to preserve residual renal functionality. The use of PRFA has become more and more widespread due to a rise in the incidental detection of renal cell carcinomas with the ever-increasing use of Imaging for the study of abdominal diseases. Clinical studies indicate that RF ablation is an effective therapy with a low level of risk of complications, which provides good results in selected patients over short and medium term periods of time, however up to now few long-term studies have been carried out which can confirm the effectiveness of PRFA.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Carcinoma de Células Renais
/
Ablação por Cateter
/
Neoplasias Renais
Limite:
Humans
Idioma:
En
Revista:
Radiol Med
Ano de publicação:
2014
Tipo de documento:
Article